AzTrials
AzTrials

DisasterNCT03868761

Feasibility and Efficacy of a Digital Mental Health Intervention for Teen Wildfire Survivors

A study testing Sonoma Rises in people with Disaster and PTSD, run by Stanford University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In October, 2017, Northern California experienced devastating and historic wildfires. Sonoma Rises is an app designed for anyone who was impacted by this event and is intended to help survivors of disaster find their new normal. Read more about this study

Who is it for?
Ages 13 to 17 yearsHealthy volunteers can take part
Conditions the study is for
Disaster, PTSD, Adolescent Behavior
What is being tested?
Sonoma Rises
Could I receive a placebo?
No, everyone receives an active treatment
How many people
7 participants
Where
1 siteUnited States
Study dates
1 Apr 2019to 22 Nov 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 17 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Males \& females aged 13-17 years directly impacted by the 2017 wildfires having lost their home or been temporarily displaced
  • Screen positive for PTSD (Child Trauma Screening Questionnaire = 5 or higher)
  • Have regular access to a smart phone and a computer
  • Have a personal email address
  • Speak and read English fluently
  • Have parental consent

Who cannot join

  • A positive self-reported history of psychosis, bipolar, or schizophrenia
  • Serious self-reported physical health concerns necessitating surgery or with prognosis <6 months
  • A positive screen for a current Substance User Disorder (CRAFFT = 2 or higher)
  • Current self-reported suicidal ideation
  • Self-reported pregnancy
  • Self-reported less than four weeks of stable prescription medication for anxiety, anti-depressant, and sleep promoting medications prior to the screening assessment

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Stanford University

    Palo Alto, California, 94304

Other trials in United States

About this study

Official title: Feasibility and Preliminary Efficacy of a Digital Mental Health Intervention to Reduce Symptoms of Post-Disaster Traumatic Stress, Depression, and Anxiety in Teens Impacted by Wildfires: A Randomized Multiple-Baseline Single-Case Study.

In October, 2017, Northern California experienced devastating and historic wildfires. Sonoma Rises is an app designed for anyone who was impacted by this event and is intended to help survivors of disaster find their new normal. This study will assess the feasibility and efficacy of a self-help post-disaster mental health intervention delivered via a mobile app with a sample of teens who are experiencing post-disaster mental health symptoms.

Being tested
Sonoma Rises
Keywords
Mobile app, Disaster, Digital Medicine, Teens
Medical subject headings
Stress Disorders, Post-Traumatic, Adolescent Behavior, Wounds and Injuries, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sonoma RisesBehavioural

    Also called Mobile Mental Health App

    All participants will receive the intervention, Sonoma Rises, a mobile app designed by psychologists at the National Center for PTSD for wildfire survivors to facilitate recovery from disaster. Users can access evidence-informed tools to help cope with stress, heal from loss, prioritize self-care, connect with others, manage anger, and track their mood using validated assessments. There are also tools designed just for teens and users are linked to psychoeducation on disaster and health and other mental health resources and services.

Study groups in NCT03868761
Study groupRoleWhat they receive
Single ArmOther21 male and female teenage participants will be randomized to one of three varying baseline assessment periods of two, four, or six weeks. Multiple baseline is a type of single-case experimental design (SCED) that is a time- and cost-effective method for evaluating efficacy of a new treatment, Sonoma Rises. The randomization of participants to baseline periods of varying lengths enables assessment of whether symptom changes occur when, and only when, the intervention is applied.
Receives: Behavioral: Sonoma Rises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility: intervention retention: number of treatment completers

    retention (i.e., number of treatment completers)

    Measured: 4 months

  2. Feasibility: intervention safety: number of adverse events

    safety (i.e., number of adverse events)

    Measured: 4 months

  3. Feasibility: intervention adherence: number of treatment components completed

    adherence rates (i.e., number of treatment components completed)

    Measured: 4 months

  4. Feasibility: intervention satisfaction/acceptability

    satisfaction/acceptability (i.e., participant satisfaction with treatment "how would you rate your overall satisfaction with the program?"- range 0-10 - higher score indicates more satisfaction)

    Measured: 4 months

  5. Feasibility: intervention promotion

    Net promoter score (i.e., "How likely are you to recommend this to a friend?" score range 0-5; lower score indicates higher likelihood of promotion)

    Measured: 4 months

  6. Feasibility: engagement rate

    Engagement rate (i.e., Number and average length of logins to the mobile app intervention)

    Measured: 4 months

  7. PTSD Symptom Severity

    Child PTSD Symptom Scale for Diagnostic and Statistical Manual-5; score ranges from 0-80; higher scores indicate more PTSD symptom severity

    Measured: 4 months

  8. PTSD functional impairment

    Child PTSD Symptom Scale for Diagnostic and Statistical Manual-5; score ranges from 0-7; higher scores indicate more PTSD related functional impairment

    Measured: 4 months

Secondary outcomes (3)
  1. Internalizing symptoms

    Behavior and Feelings Survey - Youth; range 0-24; higher scores indicate more internalizing symptoms (anxiety, depression, stress)

    Measured: 4 months

  2. Externalizing symptoms

    Behavior and Feelings Survey- Youth; range 0-24; higher scores indicate more externalizing symptoms (behavior problems)

    Measured: 4 months

  3. Psychosocial functioning

    Ohio Youth Scale - Functioning Subscale; Score range 0-80; higher score indicated better functioning

    Measured: 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Mar 2019
  2. Study start1 Apr 2019
  3. Primary completion31 Jan 2020
  4. Study completion22 Nov 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
The study will be a randomized, open label non-concurrent multiple-baseline experimental study with participants acting as their own controls.
Masking
None (open label)
Enrolment
7 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03868761
Sponsor's protocol ID
IRB-49196
Status last verified
Nov 2020
First submitted
5 Mar 2019
Last updated
24 Nov 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Sonoma Rises in people with Disaster and PTSD, run by Stanford University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility: intervention retention: number of treatment completers (time frame: 4 months). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in